CYP2D6 and psychotic disorder: The results of our analysis show that there is no correlation between CYP2D6 phenotype and chlorpromazine-equivalent dose when all drugs for psychosis are considered together, nor for only those for which PGx guidelines are available (Beunk et al., 2023).